|
Post by uvula on Aug 1, 2022 9:56:46 GMT -5
Peppy, it is nice to know you are thinking of me. I read the chit. How tall are you? Odd question. On the internet I'm 6'2". In real life I'm quite a bit shorter. But I'm not short when it comes to mnkd.
|
|
|
Post by prcgorman2 on Aug 1, 2022 10:26:02 GMT -5
perhaps some group calculated, with not much cash outlay, a short squeeze could be initiated? 1,561,146 Avg. Volume 6,009,104 3.7700. +0.3200 (+9.2754%) As of 10:49AM EDT. Market open. 1,561,146 times, 3.77 = 5.88 million added, there was some legislation, there was a Washington post article, medication costs, insulin wasn't in there, over looked, being added in, you know the $35 dollar co-pay if insured, however, additionally, Legislation wise, I believe there was blurb for more infectious disease control and some money associated with those goals. Just can not rule out something in Washington affecting a stock. Or the Reddit kiddies.
|
|
|
Post by MnkdWASmyRtrmntPlan on Aug 1, 2022 10:33:19 GMT -5
11:30 and still $3.78. It shot almost straight up $.34 this morning, hit $3.78 and took a right-turn. I see the Board gave themselves a gang of more stocks. No more news that I have found.
|
|
|
Post by MnkdWASmyRtrmntPlan on Aug 1, 2022 15:09:32 GMT -5
And it ended at $3.58, which was about at the mid-way point for the day. I really expected a run-up to the CC like usual. I just don't understand this stock. There is usually a run-up, and then back down after the CC. But when things get looking good for this stock ... nothing. SMH But there was volume and it ended up $.13 today Still two more trading days to go before CC. We'll see.
|
|
|
Post by mymann on Aug 1, 2022 15:33:33 GMT -5
We don't even get a run up to cc or fda clean label approval. It's not another buying opportunity. Something smells rotten?
|
|
|
Post by akemp3000 on Aug 1, 2022 16:05:00 GMT -5
We don't even get a run up to cc or fda clean label approval. It's not another buying opportunity. Something smells rotten? Agree...It's the current economy
|
|
|
Post by prcgorman2 on Aug 1, 2022 16:11:34 GMT -5
We don't even get a run up to cc or fda clean label approval. It's not another buying opportunity. Something smells rotten? Why do you expect or think there should be a run up to an earnings report?
On a completely different subject, why do you bring an "FDA clean label approval" into question? Did Mannkind publish news that an Afrezza label free of a black-box-warning was being requested for FDA approval?
What do you mean "it" is not another buying opportunity? i.e., what isn't another buying opportunity? The current share price, or something else?
Lastly, both the Dow and NASDAQ were down, but today's MNKD volume above 4 million shares traded was more than most recent days and the share price improved almost 4%. If the definition of a "run up" is an increase in volume and share price, than I suppose we could say at least today was a "run up" for whatever that's worth.
|
|
|
Post by mymann on Aug 1, 2022 18:28:51 GMT -5
We're in a terrible market market currently but with UTHR Tyvaso DPI approval and potential royalty coming in would be good news for sp. The poll we took about post approval sp was fun but showed no one knows about anything.
|
|
|
Post by lex8955 on Aug 1, 2022 19:19:22 GMT -5
The run up occurs tomorrow if there’s going to be one. When UTHR reports on Wednesday we will probably have all the information that MNKD will report. That’s why this is an anomaly quarter, IMHO.
|
|
|
Post by MnkdWASmyRtrmntPlan on Aug 2, 2022 6:52:26 GMT -5
It was also an anomaly for me because the mnkd cc has been the day after UT's cc, and I had it down in my calendar for this thursday. But, first thing this morning, I opened an email from MNKD that said the cc is next Tuesday, 8/9. So, we do still have time for a little run-up. And, yesterday was a nice little starting step for that. Life is good.
|
|
|
Post by peppy on Aug 2, 2022 9:00:55 GMT -5
Not much volume MNKD counter trend move today. Perhaps more volume will come in. I just saw more come in. @ 1/2 hour of trade, real time, 256,631 shares summary, 256,733 Avg. Volume 6,011,372 $3.765. +0.185. (+5.1676%) finance.yahoo.com/quote/MNKD?p=MNKDadded, MNKD volume @ 1 hour of trade, real time, 479,241 shares. summary, 481,441 3.825. +0.245. (+6.84%) As of 10:29AM EDT. Market open. This may be a good old fashion earnings run.
|
|
|
Post by oldfishtowner on Aug 2, 2022 9:47:47 GMT -5
It smells like, it feels like, it looks like --- is it an equity offering? I am guessing that what we are seeing is the beginning of the pump phase.
|
|
|
Post by peppy on Aug 2, 2022 10:00:56 GMT -5
It smells like, it feels like, it looks like --- is it an equity offering? I am guessing that what we are seeing is the beginning of the pump phase. it occurred to me. Better be for $6.50. Although, the futures are green now. MNKD volume at 1 and 1/2 hours of trade. real time, 808,231 shares,.............. looks like over 1 million in 2 hours perhaps? summary, 811,815 Avg. Volume 6,011,372 3.8750+0.2950 (+8.2402%)
|
|
|
Post by prcgorman2 on Aug 2, 2022 10:02:43 GMT -5
Pretty good SP bump at 90 minutes in to the session (30 cents) on 800K+ volume. Bad news is, easy come, easy go.
|
|
|
Post by peppy on Aug 2, 2022 10:08:04 GMT -5
Pretty good SP bump at 90 minutes in to the session (30 cents) on 800K+ volume. Bad news is, easy come, easy go. Or, this price movement could be an actual earnings run? MNKD could run, cup and 1 and a half year handle and all? Stranger things have happened. Perhaps European shorts are giving it up, European markets are south. I'll stop making stuff up, Price needs to break and hold, $4.05. today works for me. resistance all the way up. $3.88, $3.97, $4.05
|
|